-
s Pharmacogenetics for Improving Efficacy and Safety in Drug Development and for Reducing Costs in Alzheimer’s Disease
- Source: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Volume 19, Issue 1, Apr 2022, p. 3 - 6
-
- 01 Apr 2022
Preview this article:




Pharmacogenetics for Improving Efficacy and Safety in Drug Development and for Reducing Costs in Alzheimer’s Disease, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cppm/19/1/s4-1.gif
There is no abstract available.
© Bentham Science Publishers